Dashboard PDUFA PDUFA History Dilution Watch Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...

Free to browse, no account needed Track ISPC with free AI briefings, catalyst countdowns, and dilution alerts.

ISPC · iSpecimen Inc.

Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.

$4.4M Cash on Hand

6.5mo Cash Runway

Follow ISPC by email Get an email when ISPC pushes back a promised milestone, files for a stock offering or has an FDA decision. Free, no account needed.

We send one confirmation email first. Only emails about ISPC, unsubscribe in one click. Privacy

🧪 Trial & FDA Catalysts

Dec 2025 · N/A · Recruiting · Collection and Distribution of Biospecimens for Novel Research Uses
Registry date passed, readout not confirmed

💰 Cash Runway & Dilution Risk

ISPC holds $4.4M in cash and short-term investments (as of Jun 30, 2026) and burns about $2M/quarter from operations, an estimated runway of 6.5 months at that rate (BioRadar estimate, not company guidance).

Dilution pressure: 45 · Elevated

Cash runway 6 months +30
Going-concern doubt in the latest 10-Q +15These conditions raise substantial doubt regarding the Company’s ability to continue as a going concern for a period of one year from the date these unaudited condensed financial statements are issued. 10-Q, Aug 2026

Recent financing filings on SEC EDGAR:

May 13, 2026 · Private placement (8-K Item 3.02) · 8-K
Jan 2, 2026 · Private placement (8-K Item 3.02) · 8-K

Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when ISPC files for a raise →

Get the full ISPC picture

The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for ISPC and every other ticker you follow. Card required, cancel anytime.

Start 7-day free trial →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z